Bioavailability and Distribution of Nanosilver after Oral Administration in Rats

Yuanyuan Jiang,Fei Dang,Min Li,Dongmei Zhou,Di Wu,Weilin Shi,Xuefeng Zhu
DOI: https://doi.org/10.7524/AJE.1673-5897.20160902002
2017-01-01
Asian Journal of Ecotoxicology
Abstract:Due to the unique antimicrobial properties,nanosilver (AgNP) are widely applied in many fields.However,its bioavailability,tissue distribution and excretion in rats are less known.Female Sprague-Dawley rats were treated by a single intragastic administration of 10 mg·kg-1 polyvinylpyrrolidone-AgNPs,and rat tissues,feces and urine were collected periodically to analyze total Ag concentrations by ICP-MS.The results showed that after uptake by gastrointestine,AgNP was transported via the blood circulation and distributed to tissues such as liver,kidney,spleen,lung,and brain.At 1 h after AgNP exposure,total silver accumulation in those tissues peaked (i.e.0.29 ± 0.13 mg·kg-1,0.23 ± 0.04 mg·kg-1,0.17 ± 0.05 mg·kg-1,0.11 ± 0.01 mg·kg-1 and 0.06 ± 0.02 mg·kg-1 for liv er,kidney,spleen,lung and brain,respectively),and declined to background levels over time.Our calculation showed that the bioavailability of AgNP to Sprague-Dawley rats via intragastric administration was 8.5%.Especially,73% of the dosed AgNP was excreted via feces.
What problem does this paper attempt to address?